Interestingly, this phenomenon is characteristic for Rb pathway regulated genes, as it has been observed that ER+ breast cancers show a strong association between a high Rb-loss gene expression signature and poor patient prognosis, whereas the opposite is seen for ER- breast cancer patients [40]. The gene discussed is RB1; the disease is breast cancer.